作者: B. Herrmann
关键词: Medicine 、 Preliminary analysis 、 Abbott Diagnostics 、 Chlamydia trachomatis 、 Demography 、 Cobas amplicor 、 New variant 、 Chlamydia 、 Genetic variants 、 Roche Diagnostics 、 Immunology
摘要: A thrilling story in Sweden, with global impact A new variant of Chlamydia trachomatis was discovered Sweden 2006. This contains a mutant sequence that cannot be detected either the Abbott m2000 (Abbott Diagnostics, Chicago, IL, USA) or Cobas Amplicor/TaqMan48 (Roche Basel, Switzerland) systems.1 The first description reported constituted 13% all chlamydia infections (from mid-September to October 2006) county Halland (south west Sweden). It soon became apparent proportion higher and had spread widely Sweden.2–4 We now know counties have used Roche test systems during past year so accounts for 20% 65% cases. In local areas, as many 78% cases been found mutation (Britta Lore, personal communication). How great is national impact this emerging C ? As other countries rates increased 10 years. However, 2006 figures showed reversal trend.5 2% decrease because inability some diagnostic detect variant. Counties using fewer compared 2005, while methods strain, mainly BectonDickinson ProbeTec, an increase. preliminary analysis, if we assume …